Can At-Home eye scans personalize wet AMD treatment?

NCT ID NCT07744984

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study tests whether a home eye-scanning device can improve care for people with wet age-related macular degeneration (AMD) who are switching to the medication faricimab. Participants will scan their own retinas at home several times a week, and the images will be sent to their doctors for review. The goal is to see if this frequent monitoring helps detect changes sooner and supports more personalized treatment decisions, potentially extending the time between injections.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
faricimab (an anti-VEGF eye injection) plus a home optical coherence tomography (OCT) device for self-imaging
What this could lead to
If it works, this could show that home eye scans help doctors adjust wet AMD treatment faster and more precisely, potentially leading to better vision outcomes and fewer clinic visits.
What could go wrong
This is a very small study (12 people) and early-stage, so results may not apply broadly. The home device requires regular self-imaging, which may be challenging, and faricimab may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION (AMD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rabin Medical Center

    Petah Tikva, Israel, 4941492, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.